A Conversation with Joel Edwards, Humimic Medical
March 5, 2025
Humimic Medical, an SCRA Member Company, is an industry leader in high-grade medical products. Their first invention, the ballistic gel, is best known for setting the standard for durability, quality, and reusability in synthetic medical gelatins. Medical professionals worldwide use Humimic’s gelatins for simulations, phantom imaging, and to train with realism. Healthcare innovators also rely on their reusable gelatins for their products.
In February 2019, Humimic was announced as an SCRA Member Company. In May 2022, Humimic received a $50,000 Acceleration Grant.
Over the past three years, Humimic Medical has been at the forefront of innovation in medical simulation, expanding its product line to enhance realism, durability, and accessibility for healthcare training. They have introduced cutting-edge synthetic gel formulations that provide an even more lifelike experience for surgical training and medical education.
In 2025, their strategic focus is on advancing product development through material science innovation, strengthening partnerships with medical institutions, and expanding their global footprint. Additionally, they are investing more in advertising and marketing to increase brand awareness and ensure our high-quality simulation products reach a broader audience. Their commitment remains to revolutionize medical training by bridging the gap between education and real-world application.
Below is the podcast version of SCRA’s interview with Joel Edwards, CEO of Humimic Medical.
You can also listen to this podcast on Spotify. Just search for the SCRA CEO Podcast. It is also embedded below.
